Skip to content
healthcare.dev
Get a free key

Oseltamivir Phosphate for Oral Suspension

NDC 47781-384, Oseltamivir Phosphate, powder, for suspension, from Alvogen Inc..

Product NDC
47781-384
Status
Listed
Labeler
Alvogen Inc.
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208823
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47781-384 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OSELTAMIVIR PHOSPHATE6 mg/mL

Pharmacologic classes

Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]

Package NDCNDC-11Package
47781-384-26477810384261 BOTTLE, GLASS in 1 CARTON (47781-384-26) / 60 mL in 1 BOTTLE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/82df3237-636b-7bf9-3ba0-2b476e74bf4c

  • NADAC price for package 47781038426

    GET /v1/drugs/nadac/47781038426

Use it

Look up 47781-384 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47781-384 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47781-384. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.